Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Oldenburg

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
The Laryngoscope|February 18, 2020
The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-upJakob Skalleberg, Milada Cvancarova Småstuen, Jan Oldenburg, et al.
Journal of Translational Medicine|December 29, 2007
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional studyJan Oldenburg, Sigrid M Kraggerud, Marianne Brydøy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor massesJan Oldenburg, G Cecilie Alfsen, Hans H Lien, et al.
Journal of Gynecologic Oncology|May 11, 2019
Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancerMarius C Normann, Martin Türzer, Lien My Diep, et al.
BJU International|October 23, 2023
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challengePeter C Albertsen, Lars Johan Bjerner, Lara Pasovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivorsMette Sprauten, Marianne Brydøy, Hege S Haugnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patientsSophie D Fosså, Milada Cvancarova, Linlin Chen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 29, 2015
[Treatment for stage I-testicular cancer should be assessed individually]Jan Oldenburg, Hege Sagstuen Haugnes, Olav Dahl, et al.
Urology|October 12, 2011
Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Andrew J Stephenson, Armen G Aprikian, Timothy D Gilligan, et al.
Biomechanics and Modeling in Mechanobiology|August 9, 2025
Impact of calcifications on paravalvular leakage by transcatheter aortic valve prostheses: findings from a new in silico clinical trial frameworkLaura Supp, Jan Oldenburg, Matthias Leuchter, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
The Laryngoscope|February 18, 2020
The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-upJakob Skalleberg, Milada Cvancarova Småstuen, Jan Oldenburg, et al.
Journal of Translational Medicine|December 29, 2007
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional studyJan Oldenburg, Sigrid M Kraggerud, Marianne Brydøy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor massesJan Oldenburg, G Cecilie Alfsen, Hans H Lien, et al.
Journal of Gynecologic Oncology|May 11, 2019
Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancerMarius C Normann, Martin Türzer, Lien My Diep, et al.
BJU International|October 23, 2023
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challengePeter C Albertsen, Lars Johan Bjerner, Lara Pasovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivorsMette Sprauten, Marianne Brydøy, Hege S Haugnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patientsSophie D Fosså, Milada Cvancarova, Linlin Chen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 29, 2015
[Treatment for stage I-testicular cancer should be assessed individually]Jan Oldenburg, Hege Sagstuen Haugnes, Olav Dahl, et al.
Urology|October 12, 2011
Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Andrew J Stephenson, Armen G Aprikian, Timothy D Gilligan, et al.
Biomechanics and Modeling in Mechanobiology|August 9, 2025
Impact of calcifications on paravalvular leakage by transcatheter aortic valve prostheses: findings from a new in silico clinical trial frameworkLaura Supp, Jan Oldenburg, Matthias Leuchter, et al.
Pageof 10